Corvus Pharmaceuticals CRVS
NASDAQ CRVS
$10.93 -0.59 (-5.12%)
At close: Oct 1, 2026 · 4:00 PM EDT

Corvus Pharmaceuticals (CRVS) Other Operating Expenses (2016 - 2026)

Updated

Corvus Pharmaceuticals' Other Operating Expenses was $4.15 million in Q2 2026, up 389.9% from $848,000 a year earlier and up 115.9% from the prior quarter.

Analysis

Corvus Pharmaceuticals (CRVS) Other Operating Expenses (2016 - 2026) Analysis & Trends

On a trailing twelve-month basis, Corvus Pharmaceuticals' Other Operating Expenses was $7.54 million through Jun 30, 2026, up 141.5% year-over-year.

  • The Q2 2026 figure marks the highest quarterly Other Operating Expenses in data going back to Q4 2016.
  • Compared with a year earlier, Other Operating Expenses was higher in three of the last five quarters, with growth averaging 104.3%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Corvus Pharmaceuticals 969.07 Mn 457.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.15 Mn
Mar 31, 2026 1.92 Mn
Sep 30, 2025 617,000.00
Jun 30, 2025 848,000.00
Mar 31, 2025 949,000.00
Sep 30, 2024 776,000.00
Jun 30, 2024 551,000.00
Mar 31, 2024 994,000.00
Dec 31, 2016 -1,000.00
API Access

Corvus Pharmaceuticals Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=CRVS&period=max&api_key=YOUR_API_KEY